WASHINGTON, Nov. 17, 2026 — The United States has lost its status as a country that has eliminated endemic measles transmission after the same virus lineage circulated continuously for at least 12 months, the Pan American Health Organization announced Tuesday. Mexico and Bolivia also lost their national elimination status following the organization’s regional review.
The decision marks a significant reversal for the United States, which had maintained measles elimination status since 2000. PAHO said its independent Regional Monitoring and Re-Verification Commission reviewed epidemiological and laboratory evidence from countries across the Americas at a meeting held Nov. 10–13. The commission concluded that endemic transmission had been re-established in the three countries, and PAHO Director Jarbas Barbosa accepted its recommendation.
PAHO defines endemic transmission as the uninterrupted circulation of the same measles virus genotype and lineage for 12 months or longer. The designation does not mean every case in the United States is connected to one outbreak, nor does it mean measles is present in every community. It means transmission has persisted long enough that the country can no longer be considered free of ongoing domestic spread under the regional verification standard.
How the status was lost
PAHO said the U.S. outbreak began on Jan. 20, 2025, and reached the 12-month threshold in January 2026. The organization’s Nov. 17 update said the Americas had recorded 58,213 confirmed measles cases and 82 deaths as of Nov. 13, compared with 12,806 cases over the same period a year earlier. Those figures cover the entire region, not the United States alone.
The Associated Press reported that the United States had recorded more than 5,000 confirmed cases in 2026, the highest annual total since 1991. Reuters separately reported that the CDC had confirmed 5,412 cases as of Nov. 12. National case and death totals can differ by reporting cutoff and surveillance method, so they should not be combined with PAHO’s region-wide figures. The key factor in PAHO’s decision was the duration of continuous transmission, not a single case or death count.
In a statement released Tuesday, the Centers for Disease Control and Prevention said it would work with state, local, tribal and territorial health departments to encourage MMR vaccination, close immunity gaps and improve outbreak response. The agency said regaining elimination status will require sustained leadership and coordinated action across public health agencies, health care providers, laboratories and communities.
Vaccination remains the central tool
Measles is highly contagious and can cause pneumonia, brain inflammation and other serious complications. PAHO says one infected person can transmit the virus to as many as 18 susceptible people. Two doses of the measles, mumps and rubella vaccine are about 97% effective, and the organization says communities need at least 95% coverage with both doses to prevent sustained outbreaks.
National vaccination averages can hide local gaps. A county or school district with lower coverage can experience rapid spread even when the statewide rate appears comparatively strong. Health officials therefore emphasize reaching under-vaccinated communities, improving access to routine childhood immunizations and ensuring that families can obtain reliable information from clinicians and public health agencies.
What it means for U.S. readers
Losing elimination status does not automatically change vaccine requirements, travel rules or the CDC’s authority to respond to outbreaks. It is a public-health warning that the virus has regained a foothold and that preventable exposure is more likely. Parents should review children’s vaccination records with a health professional, while adults who are unsure of their immunity can ask a clinician whether vaccination or testing is appropriate.
To regain the designation, the United States must interrupt endemic transmission and demonstrate that the same lineage has not circulated continuously for another 12 months. PAHO said it will continue supporting vaccination campaigns, laboratory surveillance and outbreak response across the region. The designation can be regained, but doing so will require sustained coverage rather than a short-term decline in reported cases.



